ECSP003498A - HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROFURAN-3-CARBOXILICOS - Google Patents

HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROFURAN-3-CARBOXILICOS

Info

Publication number
ECSP003498A
ECSP003498A ECSP003498A ECSP003498A EC SP003498 A ECSP003498 A EC SP003498A EC SP003498 A ECSP003498 A EC SP003498A EC SP003498 A ECSP003498 A EC SP003498A
Authority
EC
Ecuador
Prior art keywords
cancer
treatment
hydroxiamides
carboxilicos
arilsulfonilamino
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Lawrence Alan Reiter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003498 priority Critical patent/ECSP003498A/en
Publication of ECSP003498A publication Critical patent/ECSP003498A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de fórmula (gráfico), en la que R1,R2 y Q son como se han definido antes, que es útil en el tratamiento de una artritis (incluyendo osteoartritis y artritis reumatoide), cáncer (tal como cáncer de tumores sólidos incluyendo cáncer de colon, cáncer de mama, cáncer de pulmón y cáncer de prostata y neoplasias hematopoyéticas incluyendo leucemias y linfomas) y otros transtornos. Además los compuestos de la presente invención se pueden usar en terapia de combinación con fármacos antiinflamatorios no esteroides (AINE) y analgésicos convencionales, y en combinación con fármacos citotóxicos como adriamicina, daunomicina, cis-platino, etopósido, taxol, taxótero y otros alcaloides como viscristina, en el tratamiento del cáncer.A compound of formula (graph), in which R1, R2 and Q are as defined above, which is useful in the treatment of arthritis (including osteoarthritis and rheumatoid arthritis), cancer (such as cancer of solid tumors including cancer of colon, breast cancer, lung cancer and prostate cancer and hematopoietic neoplasms including leukemia and lymphomas) and other disorders. In addition, the compounds of the present invention can be used in combination therapy with non-steroidal anti-inflammatory drugs (NSAIDs) and conventional analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinum, etoposide, taxol, taxotre and other alkaloids such as viscristine, in the treatment of cancer.

ECSP003498 2000-05-25 2000-05-25 HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROFURAN-3-CARBOXILICOS ECSP003498A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003498 ECSP003498A (en) 2000-05-25 2000-05-25 HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROFURAN-3-CARBOXILICOS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003498 ECSP003498A (en) 2000-05-25 2000-05-25 HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROFURAN-3-CARBOXILICOS

Publications (1)

Publication Number Publication Date
ECSP003498A true ECSP003498A (en) 2001-12-28

Family

ID=42041124

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003498 ECSP003498A (en) 2000-05-25 2000-05-25 HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROFURAN-3-CARBOXILICOS

Country Status (1)

Country Link
EC (1) ECSP003498A (en)

Similar Documents

Publication Publication Date Title
AR019241A1 (en) DERIVATIVES OF HYDROXAMIC HYDROXAMIC ACID, COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE OF TREATMENT OF ARTHRITIS, CANCER AND OTHER DISEASES.
CO4890852A1 (en) MATRICIAL METALOPROTEASE INHIBITORS BASED ON PHOSPHYTES
PA8445801A1 (en) ARILSULFONYLAMINOHYDROXAMIC ACID DERIVATIVES
AR011056A1 (en) SULPHONE-DERIVED COMPOUND AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR009292A1 (en) DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO, PROCESSES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
PA8446101A1 (en) ARILSULFONIL HYDROXAMIC ACID DERIVATIVES
CY1119217T1 (en) UNION FOR CANCER EDUCATION
ES3063994T3 (en) Cd73 inhibitor, preparation method therefor and application thereof
ECSP10010349A (en) DERIVATIVES OF FTALAZINONA
BR0101241A (en) substituted gem hydroxamic acids
MX368013B (en) Cancer treatment.
CR11016A (en) ORGANIC COMPOUNDS AND THEIR USES
PE20170517A1 (en) ANTIBODY-DRUG-ANTI-PTK CONJUGATES
AR051405A1 (en) 2-CARBOXAMIDE (3-AMINO) THIOPHENE COMPOUNDS
EA201370103A1 (en) COMPOUNDS AND COMPOSITIONS FOR CANCER TREATMENT
NZ525730A (en) Compositions for antitumour treatments containing Ecteinascidin 743
UY26169A1 (en) ACID HYDROXIAMIDES 3- (ARYLSULFONYLAMINE) - TETRAHYDROFURAN-3-CARBOXYLLIC
EP1909783A4 (en) LIQUID ANALOGUES USEFUL AS ANTICANCER AGENTS
PT1181286E (en) ACID HYDROXAMIDES 3- (ARYLSULPHONYLAMINO) -TETRAHYDROPYRANE-3-CARBOXYLIC ACID
CO6501171A2 (en) DERIVATIVES OF QUINOXALINE AND ITS USE FOR THE TREATMENT OF BENIGN AND EVIL TUMORS
ECSP003494A (en) HYDROXIAMIDES OF ACIDS 3- (ARILSULFONILAMINO) -TETRAHIDROPIRAN-3-CARBOXILICOS
ECSP993100A (en) HYDROXY ACID DERIVATIVES - HYDROXAMIC PIPECOLATE
ECSP972193A (en) PHOSPHINATE BASED MATRIO METALOPROTEASE INHIBITORS
ECSP972233A (en) DERIVATIVES OF ACID ARILSULFONILAMINO HIDROXAMICO
ECSP982358A (en) CYCLE DERIVATIVES OF SULFONA